XPhyto Therapeutics



dynaCERT Inc.
Latest Comments
image_pdfimage_print

XPhyto Therapeutics Hugh Rogers talks about rapid-results virus testing

InvestorIntel’s Peter Clausi talks with Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp. (CSE: XPHY | OTCQB: XPHYF) about […]


XPhyto Therapeutics moving forward from successful prototype testing of saliva virus test

Non-invasive test can detect viral RNA in asymptomatic patients XPhyto Therapeutics Corp. (CSE: XPHY | OTCQB: XPHYF | FSE: 4XT) […]


Rapid and accurate testing the key to a return to normalcy

And here are three companies working on it. Imagine a global pandemic caused by a new virus. Apparently it has […]


Drolet Stock Note: XPhyto Therapeutics — Medical Cannabis Meets Modern Sciences

Mario Drolet President of MI3 Communications Financières Inc. (MI3) released his Stock Notes on XPhyto Therapeutics Corp. (CSE: XPHY) for […]


The Canadian Securities Exchange